ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer

Han, Zhaodong; Mo, Rujun; Cai, Shanghua; Feng, Yuanfa; Tang, Zhenfeng; Ye, Jianheng; Liu, Ren; Cai, Zhiduan; Zhu, Xuejin; Deng, Yulin; Zou, Zhihao; Wu, Yongding; Cai, Zhouda; Liang, Yuxiang*; Zhong, Weide*广州医学院; 南方医科大学; 1; 5
Frontiers in Cell and Developmental Biology2022-4-21DOI: 10.3389/fcell.2022.831329
5被引7阅读
引用收藏
分享

摘要

Given the tumor heterogeneity, most of the current prognostic indicators cannot accurately evaluate the prognosis of patients with prostate cancer, and thus, the best opportunity to intervene in the progression of this disease is missed. E2F transcription factors (E2Fs) have been reported to be involved in the growth of various cancers. Accumulating studies indicate that prostate cancer (PCa) carcinogenesis is attributed to aberrant E2F expression or E2F alteration. However, the expression patterns and prognostic value of the eight E2Fs in prostate cancer have yet to be explored. In this study, The Cancer Genome Atlas (TCGA), Kaplan-Meier Plotter, Metascape, the Kyoto Encyclopedia of Genes and Genomes (KEGG), CIBERSORT, and cBioPortal and bioinformatic analysis were used to investigate E2Fs in patients with PCa. Our results showed that the expression of E2F1-3, E2F5, and E2F6 was higher in prostate cancer tissues than in benign tissues. Furthermore, elevated E2F1-3 and E2F5 expression levels were associated with a higher Gleason score (GS), advanced tumor stage, and metastasis. Survival analysis suggested that high transcription levels of E2F1-3, E2F5, E2F6, and E2F8 were associated with a higher risk of biochemical recurrence. In addition, we developed a prognostic model combining E2F1, E2F6, Gleason score, and the clinical stage that may accurately predict a biochemical recurrence-free survival. Functional enrichment analysis revealed that the E2F family members and their neighboring genes were mainly enriched in cell cycle-related pathways. Somatic mutations in different subgroups were also investigated, and immune components were predicted. Further experiments are warranted to clarify the biological associations between Pca-related E2F family genes, which may influence prognosis via the cell cycle pathway.

学科与关键词

关键词
prostate cancerE2F transcription factorsprognosisbiochemical recurrencebioinformatic analysis
相关
加载中…
  • Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer
    Liang, Yu-Xiang; Liang, Ying-Ke; Zou, Zhi-Hao; Zhuo, Yang-Jia; Ye, Jian-Heng; Zhu, Xue-Jin; Cai, Zhou-Da; Lin, Zhuo-Yuan; Mo, Ru-Jun; Wu, Shu-Lin; Zhang, Yan-Qiong*; Zhong, Wei-De*DISEASE MARKERS, 2022, 2022: 8724035.
  • EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis
    Du, Tian-Qi; Liu, Ruifeng; Zhang, Qiuning*; Luo, Hongtao; Liu, Zhiqiang; Sun, Shilong; Wang, Xiaohu*Biomolecules, 2022, 12(11): 1617.被引 1
  • FCGR3A: A new biomarker with potential prognostic value for prostate cancer
    Zha, Zeyu; Hong, Yuan; Tang, ZhenFeng; Du, Qiuling; Wang, Yan; Yang, Shengbang; Wu, Yongding; Tan, Huijing; Jiang, Funneng; Zhong, Weide*Frontiers in Oncology, 2022, 12: 1014888.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2022-04-21
卷期
第 10 卷
页码
831329
DOI
10.3389/fcell.2022.831329
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82103359, 82072813, 82002699]; Natural Science Foundation of Guangdong Province [2020A1515010473, 2018A030313668, 2020A1515110792]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110064]; Dongguan People's Hospital Doctoral Initial Foundation [K202011]; Guangdong Medical Science Research Project [A2022149]

作者

  • H

    Han, Zhaodong (第一作者)

    1

  • M

    Mo, Rujun

    southern med univ

查看全部 15 位作者收起作者
  • C

    Cai, Shanghua

    1 · guangzhou med univ

  • F

    Feng, Yuanfa

    1 · guangzhou med univ

  • T

    Tang, Zhenfeng

    1 · guangzhou med univ

  • Y

    Ye, Jianheng

    1

  • L

    Liu, Ren

    1

  • C

    Cai, Zhiduan

    5 · guangzhou med univ

  • Z

    Zhu, Xuejin

    guangzhou med univ

  • D

    Deng, Yulin

    1 · guangzhou med univ

  • Z

    Zou, Zhihao

    1

  • W

    Wu, Yongding

    1

  • C

    Cai, Zhouda

    1

  • L

    Liang, Yuxiang (通讯)

    1

  • Z

    Zhong, Weide (通讯)

    1 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417